Compounds > deferasirox
Page last updated: 2024-09-05

deferasirox and Hemophilia A

deferasirox has been researched along with Hemophilia A in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Coeleveld, K; Lafeber, FPJG; Mastbergen, SC; Pulles, AE; Schutgens, REG; van Vulpen, LFD1
Biesma, DH; Coeleveld, K; Lafeber, FP; Mastbergen, SC; Nieuwenhuizen, L; Roosendaal, G; Schutgens, RE1
Haghpanah, S; Karimi, M1

Other Studies

3 other study(ies) available for deferasirox and Hemophilia A

ArticleYear
On-demand treatment with the iron chelator deferasirox is ineffective in preventing blood-induced joint damage in haemophilic mice.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2021, Volume: 27, Issue:4

    Topics: Animals; Cartilage, Articular; Deferasirox; Hemarthrosis; Hemophilia A; Iron Chelating Agents; Mice

2021
Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Animals; Benzoates; Cartilage, Articular; Chelation Therapy; Deferasirox; Drug Evaluation, Preclinical; Ferritins; Hemarthrosis; Hemophilia A; Iron Chelating Agents; Mice; Mice, Mutant Strains; Random Allocation; Synovitis; Triazoles

2014
The effects of economic sanctions on disease specific clinical outcomes of patients with thalassemia and hemophilia in Iran.
    Health policy (Amsterdam, Netherlands), 2015, Volume: 119, Issue:2

    Topics: Adolescent; Adult; Benzoates; Child; Child, Preschool; Deferasirox; Deferoxamine; Female; Ferritins; Health Status; Hemophilia A; Humans; Internationality; Iran; Male; Plasma; Surveys and Questionnaires; Thalassemia; Triazoles; Young Adult

2015